SRTA

#2886
Strata Critical Medical, Inc. - Class A Common Stock
5.9 7 USD
-0.03%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
5.97
5.97
Jahresspanne
3.85
6.50
Tagesänderung
-3.24%
Monatliche Änderung
+16.83%
6 month change
+42.14%
Jahresänderung
+38.19%
Vorheriger Schlusskurs
6.1 7
Open
5.9 7
Tief
5.9 7
Hoch
5.9 7
Volumen
62
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Documents

2026

Current report, Q3 FY2026
Strata Critical Medical, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Strata Critical Medical, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Strata Critical Medical, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Strata Critical Medical, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Strata Critical Medical, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Strata Critical Medical, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Strata Critical Medical, Inc. current report, Q1 FY2026
8-K

2025

Annual report, FY2025
Strata Critical Medical, Inc. annual report, FY2025
10-K
Current report, Q4 FY2025
Strata Critical Medical, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Strata Critical Medical, Inc. current report, Q4 FY2025
8-K

Strata Critical Medical, Inc. current report, Q2 FY2025

Full document

Business Context and Reporting Period

This Form 8-K filing by Blade Air Mobility, Inc. (BLDE) reports on the results of the Annual Meeting of Stockholders held on May 6, 2025. The report was filed on May 8, 2025. Note: The request metadata referenced "Strata Critical Medical, Inc.," but the source text explicitly identifies the registrant as Blade Air Mobility, Inc.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.

Material Changes and Voting Results

The following proposals were submitted to a vote of security holders:

  • Election of Directors (Class I): Stockholders elected three directors to serve until the 2028 annual meeting.
    • John Borthwick: 39,268,395 votes For; 6,405,103 votes Withhold.
    • Reginald Love: 28,656,808 votes For; 17,016,690 votes Withhold.
    • Edward Philip: 43,504,327 votes For; 2,169,171 votes Withhold.
  • Ratification of Auditors: Stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
    • For: 61,959,035
    • Against: 62,680
    • Abstain: 41,238
  • Say-on-Frequency (Advisory): Stockholders approved the frequency of future advisory votes on executive compensation.
    • 1 Year: 43,748,885 votes (Majority)
    • 2 Years: 27,578 votes
    • 3 Years: 1,858,555 votes
  • Say-on-Pay (Advisory): Stockholders approved the compensation of named executive officers.
    • For: 30,045,370
    • Against: 14,947,629
    • Abstain: 680,499

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.

Important Facts for Investors to Verify

  • Verify the significant "Withhold" vote count for director Reginald Love (17,016,690 votes), which was higher than for the other two nominees.
  • Note the substantial "Against" vote for the Say-on-Pay proposal (14,947,629 votes), indicating notable shareholder dissent regarding executive compensation despite the proposal passing.
  • Confirm the high number of Broker Non-Votes (16,389,455) across multiple proposals, which may impact the effective voting power of beneficial owners.
  • Review the definitive proxy statement filed on March 24, 2025, for detailed context on the director nominees and compensation plans.